EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

I last wrote on AbbVie Inc. (NYSE: ABBV (NEOE: ABBV:CA ) and Pfizer Inc. (NYSE: PFE ) (NEOE: PFE:CA ) both back in March 2024. My last As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles per week on such ideas.We have helped our members not only to beat S&P 500 but also avoid heavy drawdowns despite the extreme volatilities in BOTH the ...

Stonegate Capital Partners Updates Coverage On GoHealth Inc. (GOCO) 2025 Q1May 14, 2025 4:36 PM EDT | Source: Reportable, Inc.Dallas, Texas--(Newsfile Corp. - May 14, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a strong first quarter in 2025, highlighted by substantial revenue growth and operational efficiencies. Net revenues surged 19.1% year-over-year to $221.0M, driven by a 40.2% increase i ...

Core Viewpoint - The New York Attorney General has filed a lawsuit against Capital One, alleging that the bank misled customers regarding the existence of a higher interest savings account, similar to previous allegations made by the Consumer Financial Protection Bureau (CFPB) [1][6]. Group 1: Allegations Against Capital One - The lawsuit claims that Capital One marketed its 360 Savings accounts as having "one of the nation's best savings rates" while keeping interest rates "artificially low" despite rising rates nationwide [2]. - It is alleged that Capital One created a "nearly identical" savings account called 360 Performance Savings, which offered interest rates up to 14 times higher than the 360 Savings account [3]. - The lawsuit accuses Capital One of intentionally misleading its 360 Savings customers about the existence of the 360 Performance Savings account to avoid paying them additional interest [3]. Group 2: Responses from Capital One - A spokesperson for Capital One stated that the bank "strongly" disagrees with the attorney general's claims and intends to "vigorously defend" itself in court [4]. - Capital One emphasized its pride in the 360 suite of banking products, asserting that they offer great rates with no fees and no minimums, and that the 360 Performance Savings product was widely marketed [5].

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

Netflix is adding more live streaming content, the company announced at its Upfront presentation on Wednesday. The service, which now reaches over 94 million global monthly active users, has been steadily introducing live TV to its audience with sports content from WWE wrestling, comedy, and awards shows, and other special events (some of which definitely didn’t work out.)According to Netflix Chief Content Officer Bela Bajaria, the company will be adding new programs, including the Katie Taylor vs. Amanda S ...

CRANFORD, N.J., May 14, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported business and financial results for the fiscal second quarter ended March 31, 2025."In Q2 2025, Citius Oncology advanced its transformation from a development-stage company to a commercial-stage organization. Following FDA approval of LYMPHIR, we intens ...

CRANFORD, N.J., May 14, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal quarter ended March 31, 2025."As we continue to focus on the planned launch of our first FDA-approved product, LYMPHIR, through Citius Oncology, we are actively engaged in securing the necessary financing t ...

CLEVELAND, May 14, 2025 /PRNewswire/ -- Avient Corporation (NYSE: AVNT), an innovator of materials solutions, today announced that its Board of Directors has appointed Ashish K. Khandpur, Ph.D., Avient's President, Chief Executive Officer and Director, to serve in the additional role of Chairman of the Board, effective May 14, 2025.Dr. Khandpur succeeds Richard H. Fearon, who had served as Chairman of the Board of Directors since December 2023 and will continue to serve on the Board.  Dr. Ashish K. Khan ...

Core Viewpoint - Cango Inc. reported significant growth in the first quarter of 2025, primarily driven by its entry into the Bitcoin mining industry, resulting in total revenues of RMB1.1 billion (US$145.2 million), a substantial increase from RMB64.4 million in the same period of 2024 [3][5][10]. Financial Performance - Total revenues for Q1 2025 were RMB1.1 billion (US$145.2 million), compared to RMB64.4 million in Q1 2024, marking a year-over-year increase of approximately 1,610% [5][8]. - Revenue from Bitcoin mining was RMB1.0 billion (US$144.2 million), with 1,541 Bitcoins mined during the quarter, up from 933.8 Bitcoins in the previous quarter [3][5]. - Revenue from automotive trading-related income was RMB7.6 million (US$1.0 million), a decrease from RMB64.4 million in the same period of 2024 [6]. Operating Costs and Expenses - Total operating costs and expenses in Q1 2025 were RMB1.2 billion (US$166.7 million), primarily related to Bitcoin mining operations [7][8]. - The cost of revenue for Bitcoin mining was RMB955.1 million (US$131.6 million), compared to RMB29.1 million in Q1 2024 [7][8]. Profitability Metrics - Loss from operations in Q1 2025 was RMB155.5 million (US$21.4 million), compared to income from operations of RMB74.2 million in Q1 2024 [9]. - Net loss for the quarter was RMB207.4 million (US$28.6 million), a decline from net income of RMB90.0 million in the same period of 2024 [10][30]. - Adjusted EBITDA was RMB27.6 million (US$3.8 million), down from RMB108.4 million in Q1 2024 [11][30]. Balance Sheet and Cash Position - As of March 31, 2025, cash and cash equivalents totaled RMB2.5 billion (US$347.4 million), an increase from RMB1.3 billion as of December 31, 2024 [16]. - The total outstanding balance of financing transactions facilitated by the company was RMB2.6 billion (US$358.4 million) as of March 31, 2025 [8]. Business Outlook - The company aims to increase its computing power from 32 EH/s to approximately 50 EH/s by the end of July 2025, enhancing its position among top-tier Bitcoin miners [3][12]. - Cango plans to continue optimizing its existing resources and explore high-quality M&A opportunities to scale operations and deliver long-term value [3][12].